A Promising Marker for Carotid Artery Disease: Monocyte to High-density Lipoprotein Cholesterol Ratio
Yıl: 2020 Cilt: 10 Sayı: 1 Sayfa Aralığı: 93 - 98 Metin Dili: İngilizce DOI: 10.31832/smj.644699 İndeks Tarihi: 23-05-2021
A Promising Marker for Carotid Artery Disease: Monocyte to High-density Lipoprotein Cholesterol Ratio
Öz: Objective The aim of our study was to evaluate the relation between monocyte/high-density lipoprotein cholesterol (HDL-C) ratio value and carotid artery stenosis in patients whounderwent carotid angiography.Materialsand MethodsTo our study, 103 participants were enrolled (70 patients, 33 healthy individuals) who attended the cardiovascular surgery policlinic and had carotid angiography inbetween January 2017 and June 2018. Participants were divided into two groups, who have carotid artery disease and who don't. Peripheral venous blood results, taken fromall patients before angiography for hematologic examination, were evaluated. Groups were compared according to their monocyte/high-density lipoprotein cholesterol(HDL-C) values and other hematologic results.Results Monocyte/high-density lipoprotein cholesterol (HDL-C) ratio and monocyte values were found to be higher in the group with a carotid artery disease compared to thegroup with a normal carotid angiography (0.018±0.009 vs. 0.013±0.007 p= 0.008; 0.67±0.28 vs. 0.51±0.24 p=0.007). There was no significant difference between groupsconsidering demographic features and other hematological paramaters.Conclusions In our study, it was shown that high monocyte/high-density lipoprotein cholesterol (HDL-C) ratio value could be a predictor for the diagnosis of obstructive carotid arterydisease
Anahtar Kelime: Karotis Arter Hastalığı için Umut Verici Marker: Monosit Yüksek Yoğunluklu Lipoprotein Kolesterol Oranı
Öz: Amaç Çalışmamızın amacı karotis arter angiografisi yapılan hastalarda monosit/yüksek yoğunluklu lipoprotein kolesterol oranı değerlerinin karotis arter stenozu ile ilişkisini retrospektif olarak araştırmaktı. Gereç ve Yöntemler Çalışmamıza Ocak 2017 ile Haziran 2018 yılları arasında kalp ve damar cerrahisi polikliniğine başvuran ve karotis arter angiografisi yapılan 103 (70 hasta, 33 sağlıklı) hasta dahil edildi. Karotis arter hastalığı olanlar ve olmayanlar diye iki gruba ayrıldı. Tüm hastaların hematolojik değerlerine bakılması için angiografi öncesi alınan periferik venöz kan sonuçları tarandı. Gruplar monosit/yüksek yoğunluklu lipoprotein kolesterol oranı ve diğer hematolojik sonuçlar açısından karşılaştırıldı. Bulgular Monosit/yüksek yoğunluklu lipoprotein kolesterol oranı ve monosit değeri karotis arter hastalığı olanlar grubunda karotis arter angiografisi normal çıkan gruba göre anlamlı olarak yüksek bulundu (0.018±0.009 vs. 0.013±0.007 p= 0.008; 0.67±0.28 vs. 0.51±0.24 p=0.007). Diğer hematolojik parametreler ve demografik veriler açısından gruplar arasında anlamlı bir farklılık yoktu. Sonuç Çalışmamızda yüksek monosit/yüksek yoğunluklu lipoprotein kolesterol oranının karotis arter hastalığı tanısında bir öngördürücü olabileceği gösterildi.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, et al. 2011 ASA/ACCF/ AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/ SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Circulation 2011;124:e54- 130.
- 2. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clement D, Collet JP, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2851-2906.
- 3. Hansson GK, Libby P, Schonbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002;91:281–291.
- 4. Hansson G. Infl ammatory mechanisms in atherosclerosis. J Th romb Haemost 2009;7:328– 331.
- 5. Aşkın L, Çetin M, Türkmen S, Taşolar H, Aktürk E. Th e relationship between monocyte/high-density lipoprotein ratio and Selvester QRS score in patients with STEMI. Turk Kardiyol Dern Ars 2018;46(4):260-267.
- 6. Olivares R, Ducimetière P, Claude JR. Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol 1993;137 (1):49–53.
- 7. Hafiane A, Genest J. High density lipoproteins: measurement techniques and potential biomarkers of cardiovascular risk. BBA Clin 2015;3:175–188.
- 8. Zhang Y, Li S, Guo YL, Wu NQ, Zhu CG, Gao Y, et al. Is monocyte to HDL ratio superior to monocyte count in predicting the cardiovascular outcomes: evidence from a large cohort of Chinese patients undergoing coronary angiography. Ann Med 2016;48(5):305–312.
- 9. Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1990;1044:275-283.
- 10. Westerterp M, Gourion-Arsiquaud S, Murphy AJ, Shih A, Cremers S, Levine RL,et al. Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol effl ux pathways. Cell Stem Cell 2012;11:195-206.
- 11. Cetin MS, Ozcan Cetin EH, Kalender E, et al. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome. Heart Lung Circ 2016;25:1077-1086.
- 12. Aydin E, Ates I, Fettah Arikan, et al. Th e ratio of monocyte frequency to HDL cholesterol level as a predictor of asymptomatic organ damage in patients with primary hypertension. Hypertens Res 2017;40:758-764.
- 13. Vahit D, Mehmet KA, Samet Y, et al. Assessment of monocyte to high density lipoprotein cholesterol ratio and lymphocyteto-monocyte ratio in patients with metabolic syndrome. Biomark Med 2017;11:535-540
- 14. Ren H, Liu X, Wang L,Gao Y. Lymphocyte-to-monocyte ratio: a novel predictor of the prognosis of acute ischemic stroke. Journal of Stroke And Cerebrovascular Diseases 2017;26(11): 2595–2602
- 15. Ancuta P, Wang J, Gabuzda D. CD 16 monocytes produce IL-6,CCL2 and matrix metalloproteinase -9 upon interaction with CX3 CL1- expressing endoteial cells. J Leukoc Biol 2006;80:1156-1164.
- 16. Urra X, Villamor N, Amaro S, et al. Monocyte subtypes predict clinical course and prognosis in human stroke. J Cereb Blood Flow Metab 2009;29:994-1002.
- 17. Qiao JH, Tripathi J, Mishra NK, Cai Y, Tripathi S, Wang XP, et al. Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. Am J Pathol 1997;150:1687–1699.
- 18. Murphy AJ, Woollard KJ. High-density lipoprotein: a potent inhibitor of infl ammation. Clin Exp Pharmacol Physiol 2010;37:710–718.
- 19. Murphy AJ, Woollard KJ, Hoang A, Mukhamedova N, Stirzaker RA, McCormick SPA, et al. High-density lipoprotein reduces the human monocyte infl ammatory response. Arterioscler Th romb Vasc Biol 2008;28:2071–2077.
- 20. Westerterp M, Gourion-Arsiquaud S, Murphy AJ, Shih A, Cremers S, Levine RL, et al. Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol effl ux pathways. Cell Stem Cell 2012;11:195–206.
- 21. Wang N, Lan D, Chen W, Matsuura F, Tall AR. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol effl ux to highdensity lipoproteins. Proc Natl Acad Sci U S A 2004;101:9774–9779.
- 22. Kanbay M, Solak Y, Unal HU, Kurt YG, Gok M, Cetinkaya H, et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol 2014;46:1619–1625.
- 23. Tekkesin AI, Hayiroglu MI, Zehir R, Turkkan C, Keskin M, Cinier G, Alper AT. Th e use of monocyte to HDL ratio to predict postoperative atrial fibrillation aft er aortocoronary bypass graft surgery. North Clin Istanb 2017;4(2):145-150.
- 24. Bolayir A, Gokce SF, Cigdem B, Bolayir HA, Yildiz OK, Bolayir E, Topaktas SA. Monocyte/high-density lipoprotein ratio predicts the mortality in ischemic stroke patients. Neurol Neurochir Pol 2018;52(2):150-155.
- 25. Zhang Y, Li S, Guo YL, Wu NQ, Zhu CG, Gao Y, Xu RX, Dong Q, Liu G, Sun J, Li JJ. Is monocyte to HDL ratio superior to monocyte count in predicting the cardiovascular outcomes: evidence from a large cohort of Chinese patients undergoing coronary angiography. Ann Med 2016;48(5):305-312.
APA | KIRISCI M (2020). A Promising Marker for Carotid Artery Disease: Monocyte to High-density Lipoprotein Cholesterol Ratio. , 93 - 98. 10.31832/smj.644699 |
Chicago | KIRISCI MEHMET A Promising Marker for Carotid Artery Disease: Monocyte to High-density Lipoprotein Cholesterol Ratio. (2020): 93 - 98. 10.31832/smj.644699 |
MLA | KIRISCI MEHMET A Promising Marker for Carotid Artery Disease: Monocyte to High-density Lipoprotein Cholesterol Ratio. , 2020, ss.93 - 98. 10.31832/smj.644699 |
AMA | KIRISCI M A Promising Marker for Carotid Artery Disease: Monocyte to High-density Lipoprotein Cholesterol Ratio. . 2020; 93 - 98. 10.31832/smj.644699 |
Vancouver | KIRISCI M A Promising Marker for Carotid Artery Disease: Monocyte to High-density Lipoprotein Cholesterol Ratio. . 2020; 93 - 98. 10.31832/smj.644699 |
IEEE | KIRISCI M "A Promising Marker for Carotid Artery Disease: Monocyte to High-density Lipoprotein Cholesterol Ratio." , ss.93 - 98, 2020. 10.31832/smj.644699 |
ISNAD | KIRISCI, MEHMET. "A Promising Marker for Carotid Artery Disease: Monocyte to High-density Lipoprotein Cholesterol Ratio". (2020), 93-98. https://doi.org/10.31832/smj.644699 |
APA | KIRISCI M (2020). A Promising Marker for Carotid Artery Disease: Monocyte to High-density Lipoprotein Cholesterol Ratio. Sakarya Tıp Dergisi, 10(1), 93 - 98. 10.31832/smj.644699 |
Chicago | KIRISCI MEHMET A Promising Marker for Carotid Artery Disease: Monocyte to High-density Lipoprotein Cholesterol Ratio. Sakarya Tıp Dergisi 10, no.1 (2020): 93 - 98. 10.31832/smj.644699 |
MLA | KIRISCI MEHMET A Promising Marker for Carotid Artery Disease: Monocyte to High-density Lipoprotein Cholesterol Ratio. Sakarya Tıp Dergisi, vol.10, no.1, 2020, ss.93 - 98. 10.31832/smj.644699 |
AMA | KIRISCI M A Promising Marker for Carotid Artery Disease: Monocyte to High-density Lipoprotein Cholesterol Ratio. Sakarya Tıp Dergisi. 2020; 10(1): 93 - 98. 10.31832/smj.644699 |
Vancouver | KIRISCI M A Promising Marker for Carotid Artery Disease: Monocyte to High-density Lipoprotein Cholesterol Ratio. Sakarya Tıp Dergisi. 2020; 10(1): 93 - 98. 10.31832/smj.644699 |
IEEE | KIRISCI M "A Promising Marker for Carotid Artery Disease: Monocyte to High-density Lipoprotein Cholesterol Ratio." Sakarya Tıp Dergisi, 10, ss.93 - 98, 2020. 10.31832/smj.644699 |
ISNAD | KIRISCI, MEHMET. "A Promising Marker for Carotid Artery Disease: Monocyte to High-density Lipoprotein Cholesterol Ratio". Sakarya Tıp Dergisi 10/1 (2020), 93-98. https://doi.org/10.31832/smj.644699 |